Related Experiment Videos
Major histocompatibility complex markers in patients with nomifensine-induced immune hemolytic anemia
G Mueller-Eckhardt1, G Giers, A Salama
1Institute of Clinical Immunology and Blood Transfusion, University of Giessen, FRG.
Vox Sanguinis
|January 1, 1988
Abstract:
To evaluate a possible role of major-histocompatibility-complex (MHC)-related immune-response genes for the selective production of drug-induced antibodies, HLA class I (ABC), class II (DR, DQ), class III (BF, C2, C4A, C4B) as well as glyoxalase-1 allotypes were investigated in 26 patients with nomifensine-induced immune hemolytic anemia. No statistically significant deviations of MHC antigen frequencies were noted. The possible implications of these findings are discussed.